Category: News

Post

Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO™

-PDUFA action date now set for April 30, 2019- DUBLIN, Ireland , Jan. 14, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of innovative anti-infective agents to treat serious infections, announced READ FULL TEXT